PT  - JOURNAL ARTICLE
AU  - Grauer, Ken
AU  - Gums, John
TI  - Ventricular Arrhythmias, Part III: Benefits And Risks Of Antiarrhythmic Therapy
AID  - 10.3122/jabfm.1.4.255
DP  - 1988 Oct 01
TA  - The Journal of the American Board of Family
                Practice
PG  - 255--266
VI  - 1
IP  - 4
4099  - http://www.jabfm.org/content/1/4/255.short
4100  - http://www.jabfm.org/content/1/4/255.full
SO  - J Am Board Fam Med1988 Oct 01; 1
AB  - In Parts I and II of this series, clinical significance, prevalence, and special concerns in the evaluation of patients with ventricular arrhythmias were reviewed. We now examine the categories of antiarrhythmic drugs and offer indications for their use. Reasons why a patient may not respond to antiarrhythmic therapy, end points of therapy, and the benefits and drawbacks of measuring serum drug levels are addressed. Use of newer drugs and additional treatment modalities are discussed in the final installment.